Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 4Esophageal Squamous Cell Carcinoma 3Uterine Cervical Neoplasms 2Lymphatic Metastasis 2Triple Negative Breast Neoplasms 1Recurrence 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Ductal, Breast 1

Interventions

TP protocol 2pembrolizumab 1cabozantinib 1Technetium 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Adjuvant 1Radiotherapy 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Indocyanine Green 1Control Groups 1Cobalt-60 1Cisplatin 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Lymphatic Metastasis × TP protocol × Clear all
NCT03468010 2018-03-26

A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)

Sun Yat-sen University

Phase 3 Unknown
432 enrolled
Gynecologic

Uterine Cervical Neoplasms, Lymphatic Metastasis

NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Shanghai Chest Hospital

Phase 3 Unknown
486 enrolled
Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡